BioNTech SE BNTX Income Statement (2018-2026)

NASDAQ BNTX
$98.57 -0.51 (-0.51%)
At close: Sep 29, 2026 · 4:00 PM EDT
Reported Financials

BioNTech SE Quarterly Income Statement

Periods 32 quarters
Latest Jun 2026

BioNTech SE reported revenue of $122.75M and net income of -$1042.17M for the quarter ended Jun 2026, down 58.4% year over year. This income statement covers 32 quarters of results from Sep 2018 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Revenue & cost
Revenue
7,178.68M6,329.02M7,154.45M3,410.85M3,489.84M4,364.92M1,370.66M182.61M974.62M1,591.32M203.80M138.60M1,367.06M1,271.63M192.28M295.22M1,775.68M1,056.25M138.27M122.75M
Cost of RevenueCost of Rev
1,428.59M667.16M1,452.42M815.87M759.03M187.22M103.04M177.39M176.13M192.70M64.20M64.40M196.47M260.20M88.15M86.48M173.37M387.98M83.59M112.75M
Gross Profit
5,750.09M5,661.86M5,702.04M2,594.98M2,730.81M4,177.71M1,267.62M5.23M798.48M1,398.61M139.60M74.20M1,170.59M1,011.43M104.14M208.73M1,602.31M668.28M54.67M10.00M
Operating items
Research & DevelopmentR&D
-307.09M-310.59M-320.76M-426.40M-344.63M-520.12M-358.50M-406.60M-542.01M-621.68M-551.33M-629.55M-604.35M-653.77M-552.87M-576.28M-660.28M-588.31M-652.11M-640.46M
Selling, General & AdministrativeSG&A
-80.43M-149.75M-101.91M-138.72M-142.17M-122.33M-120.00M-130.45M-151.42M-133.74M-127.10M-184.04M-145.40M-118.40M-112.45M-133.23M-141.69M-196.26M-143.88M-183.30M
Other Operating ExpensesOther Opex
-31.13M-76.76M-80.36M-256.84M-287.46M-386.88M-134.92M-83.96M-40.06M-61.97M-25.96M-313.16M-451.26M-97.88M-51.02M-132.67M-852.83M-242.12M-54.79M-288.38M
Operating ExpensesOpex
-387.51M-460.33M-422.67M-565.11M-486.79M-642.45M-478.50M-537.06M-693.43M-755.42M-678.43M-813.59M-749.75M-772.17M-665.32M-709.51M-801.97M-784.57M-795.99M-823.77M
Operating IncomeOp. Inc
5,570.36M5,376.32M5,334.13M2,357.77M2,407.25M3,359.57M702.39M-613.39M79.58M566.16M-551.00M-1040.49M11.53M158.79M-561.81M-567.22M-54.83M-375.75M-793.18M-1102.04M
EBIT
5,570.36M5,376.32M5,334.13M2,357.77M2,407.25M3,359.57M702.39M-613.39M79.58M566.16M-551.00M-1040.49M11.53M158.79M-561.81M-567.22M-54.83M-375.75M-793.18M-1102.04M
Non-operating items
Non Operating Interest Expenses
-97.53M-2.40M-7.52M-6.19M-4.34M-162.32M-31.13M-1.42M-2.18M-27.11M-5.11M-7.86M-8.79M-13.46M-35.66M-7.92M-29.46M-4.89M-13.11M-9.18M
Interest & Investment IncomeInt & Inv Inc
31.37M18.65M305.39M123.25M61.40M39.59M88.34M165.95M170.15M174.52M195.65M180.59M171.54M176.53M128.96M119.31M113.16M115.94M141.19M113.10M
Other Non Operating IncomeOther Non Op Inc.
-66.16M8.12M121.64M82.98M-329.85M81.79M28.09M8.49M-22.81M1.85M172.73M162.76M111.38M
Non Operating IncomeNon Op. Inc.
61.91M8.80M16.87M17.71M
Net income details
EBT
5,504.21M5,392.56M5,632.00M2,474.82M2,464.32M3,236.84M759.60M-448.85M247.55M713.56M-360.45M-867.76M174.29M321.86M-468.51M-455.84M28.88M-264.70M-665.10M-998.12M
Tax ProvisionsTaxes
-1717.51M-1770.52M-1480.70M-690.71M-664.65M-912.00M-220.57M241.52M-72.72M-220.89M18.14M-2.15M43.27M-44.56M31.14M18.22M-62.43M-90.33M42.38M44.05M
Profit After TaxPAT
7,221.72M7,163.09M7,112.70M3,165.53M3,128.98M4,148.84M980.18M-690.38M320.26M934.45M-378.60M-865.60M131.02M366.42M-499.65M-474.06M91.30M-174.37M-707.48M-1042.17M
Equity Income
Income from Non-Controlling InterestsInc. Minority
3,622.04M
Income from Continuing OperationsIncome (Continuing)
7,221.72M7,163.09M7,112.70M3,165.53M3,128.98M4,148.84M980.18M-690.38M320.26M934.45M-378.60M-865.60M131.02M366.42M-499.65M-474.06M91.30M-174.37M-707.48M-1042.17M
Consolidated Net IncomeConsol Net Inc.
3,786.69M3,622.04M4,151.30M1,784.12M1,799.67M2,324.84M539.03M-207.33M174.83M492.67M-342.31M-869.91M217.56M277.30M-499.65M-474.06M-33.55M-355.03M-707.48M-1042.17M
Income towards Parent CompanyParent Net Inc
3,786.69M3,622.04M4,151.30M1,784.12M1,799.67M2,324.84M539.03M-207.33M174.83M492.67M-342.31M-869.91M217.56M277.30M-437.37M-437.62M-33.55M-355.03M-622.72M-954.07M
Net Income towards Common StockholdersNet Income
3,786.69M3,622.04M4,151.30M1,784.12M1,799.67M2,324.84M539.03M-207.33M174.83M492.67M-342.31M-869.91M217.56M277.30M-453.15M-437.62M-33.55M-355.03M-622.72M-954.07M
Additional items
EPS (Basic)
16.0814.8417.017.317.389.562.22-0.850.722.05-1.42-3.620.901.15-1.88-1.82-0.14-1.47-2.58-3.95
EPS (Diluted)
15.2413.9515.986.876.939.312.16-0.830.702.03-1.41-3.580.901.15-1.88-1.82-0.14-1.47-2.58-3.95
Shares Outstanding
235.44M244.00M244.00M244.00M244.00M243.30M243.30M243.30M243.30M240.60M240.60M240.60M240.60M240.40M240.40M240.40M240.40M241.70M241.70M241.70M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
248.53M259.70M259.70M259.70M259.70M249.80M249.80M249.80M249.80M242.70M242.70M242.70M242.70M240.40M240.40M240.40M240.40M241.70M241.70M241.70M
Shares Outstanding (Entity)Shares Outstanding (Entity.)
246.81M240.99M237.73M239.97M252.88M
EBITDA
5,628.38M5,406.06M5,365.11M2,393.19M2,441.03M3,389.16M736.10M-578.65M124.53M650.94M-509.40M-986.75M60.29M335.54M-516.79M-509.50M90.37M-183.92M-651.17M-792.73M
Interest ExpensesInt Expense
-97.53M-2.40M-7.52M-6.19M-4.34M-162.32M-31.13M-1.42M-2.18M-27.11M-5.11M-7.86M-8.79M-13.46M-35.66M-7.92M-29.46M-4.89M-13.11M-9.18M
Tax Rate
24.83%

BioNTech SE Income Statement API

Pull BioNTech SE's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=BNTX&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEY